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Abbreviations 
ATP adenosine triphosphate 
CIT1, CIT2 mitochondrial and peroxisomal citrate synthase respectively 
CoA coenzyme A 
cyaY, CyaY the gene and the protein of the E. coli frataxin homologue 
DNA dezoxyribonucleic acid 
E. coli Escherichia coli 
FRDA Friedreich ataxia 
GalP galactose promoter 
hGP human Graves protein 
IPMS α-isopropylmalate synthase 
α-IPM α-isopropylmalate 
β-IPM β-isopropylmalate 
LEU4, LEU5 gene encoding IPMS and its hypothetical analogue 
MDH malate dehydrogenase 
MPP mitochondrial is processing peptidase 
mtDNA mitochondrial DNA 
PCR polymerase chain reaction 
PMS post mitochondrial supernatant 
S. cerevisiae Saccharomyces cerevisiae 
SDH succinate dehydrogenase 
Tim22p trans inner membrane translocase 
YFH1, Yfh1p the gene and the protein of the yeast frataxin homologue 
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Inroduction 
 It is a well established technique in the field of molecular biology to use different 
organisms to study the function of protein homologs. There are two mayor advantages 
to use a simple organism as a model. One of them, when the originally found phenotype 
couldn’t be studied in that organism because that is so complicated, it is not possible to 
use genetic engineering, or on the other hand when  phenotype found in a simple 
organism could be more easily explained in a more complex background. One of the 
most frequently used organism as a model, is the baker’s yeast, Saccharomyces 
cerevisiae, often mentioned as the “work horse” of molecular biology. This simple 
organism has all the advantages what the scientists may whish: fast replication and easy 
genetic manipulation. However it is also suitable to study more complicated processes, 
since as an eukaryote this  organism already carries subcellular compartments like 
nucleus and mitochondria.  
The thesis based on the functional analyses of the homolog protein pairs, the human 
Graves disease protein (hGP) and its homolog the yeast Leu5p, furthermore the 
bacterial and yeast frataxin homologs the CyaY and the Yfh1p.   
The Leu5p and the hGP  
 There are several vital processes taking place in the mitochondria, like oxidative 
phosphorylation, tricarboxylic acid cycle,  β-oxidation, partially the urea cycle, the 
biosynthesis of heme and a few amino acids.  There are a large number of substances 
necessary to be transported, specifically and fast enough between the matrix of the 
mitochondria and the cytosol,  for the satisfying metabolic activity of mitochondria, 
since the inner membrane is not permeable for these components. There are a relatively 
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large number of transport proteins serving for these processes, of which there is a 
special group called mitochondrial carriers. The members of this group are sharing 
about 20-40 % of amino acid identity. There are 35 carriers known in yeast, however 
only 13 substrates of these proteins identified to date. The YHR002w gene of the S. 
cerevisiae encodes such a protein  (P38702) having all the characteristic elements of 
mitochondrial carriers. This gene has been subcloned earlier to identify a second α-
izopropylmalate dehydrogenase, in addition to the already well characterized Leu4p. 
The gene named that time as LEU5.  Since the single Δleu4 is not, but Δleu4 Δleu5 
double mutant is leucine auxotroph, it was suggested the encoded a Leu4p analog.  The 
sequence analyses of   LEU5 reviled that, Leu5p could be integrated in the 
mitochondrial inner membrane, and may be not even involved in leucine synthesis. The 
Leu5p has a human homolog called hGP a protein involved in Graves disease, with 
unknown function. The amino acid composition of these two proteins are 35 % 
identical.  
The frataxin,  Yfh1p and CyaY 
 Friedreich’s ataxia (FRDA) is the most common inherited ataxia transmitted in an 
autosomal fashion, with an occurrence of 1 or 2 in 50.000 individuals. Characteristic 
symptoms include ataxia of the limbs, areflexia, muscle weakness and skeletal 
deformities, cardiomyopathy, sensory loss, and increased incidence of diabetes mellitus.   
FRDA is caused by severely reduced levels of frataxin, a protein localized to the 
mitochondrial matrix. This 210 amino acid residues protein has been thought to be 
involved in iron homeostasis since its discovery.  However the function of frataxin is 
still controversial, its importance is reflected by the conservation during the  evolution. 
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It has been showed, that frataxin is able to bind Fe2+ in vitro, and as an iron chaperon 
also able to donate it for the biosynthesis of ISC and heme, and to repair the ISC of 
aconitase. It seems to be the mayor role of frataxin is to detoxify the excess iron of the 
mitochondria and to chaperon bioavailable iron for important processes.   
 The yeast frataxin homolog (Yfh1p) is one of the most studied form of the frataxin 
homologs. Deletion of the encoding gene, YFH1 (Δyfh1) causes a growth defect on non 
fermentable carbon source, leads to a tendency for loosing mitochondrial DNA 
(mtDNA), cells became sensitive against oxidative stress and iron accumulates in the 
mitochondria.   However the lack its bacterial homolog, the E. coli CyaY (ΔcyaY) 
causing no obvious effect to the cells. In vitro this protein also behaves similarly to its 
homologs.  Since CyaY can not be studied in vivo in its original background since 
deletion of cyaY doesn’t result change in phenotype, most likely due to its redundancy 
in this environment, we expressed this gene in a frataxin depleted S. cerevisiae. 
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Perspectives 
1.  - identify the function of Leu5p 
- complement a Δleu5 yeast strain with the human Leu5p homolog hGP 
2. - delete the cyaY in E. coli (ΔcyaY) and characterize the strain 
 - complement a Yfh1p depleted yeast strain with CyaY 
Methods 
Bacterial and yeast strains, producing mutant strains, medias 
 To subclone and to produce DNA plasmids, DH5α, to produce recombinant 
proteins, BL21, XLBlue and DH5α E. coli strains were used. CyaY deletion was carried 
out in a CLT42 strain, using a Zeocine antibiotic resistance gene. W303-1A or W303-
1B yeast strains were used as a wild type or the following mutant yeast strains were 
used: Δleu5; Δcit2; Δleu5Δcit2; Δcor1; Δcox6; Δflx1; Δmir1 and GK178. Gene deletion 
in yeast, were made by one step gene disruption. For E. coli Luria or minimal liquid 
media were used, the cultures were propagated at 37°C with shaking. Same media were 
used to prepare plates, containing 2% agar. In both liquid or solid media contained 0.4 
% of different carbon sources.    
For yeast YP rich, or synthetic media (S) were used, supplemented with glucose, 
galactose, glycerin or ethanol carbonsources, in liquid or solid form. All yeast strains 
were grown at 30°C. In the strain GK178 the expression of YFH1 is controlled by a very 
tight controlled mutant GAL1 promoter (gal1*), were the YFH1 was repressed glucose.  
Expression and purification of recombinant proteins 
 The encoding gene of hGP were amplified by PCR from cDNA, isolated from 
Jurkat celline, and cubcloned into pYes yeast expression vector.  For the production of 
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His-tagged recombinant CyaY, the encoding gene was subcloned into pQE9 E. coli 
expression vector, using a PCR amplified fragment from wild type E. coli chromosomal 
DNA. The protein was purified by Ni-agarose beads. Wild type CyaY was purified by 
chromatography in a similar way to that of Yfh1p, due to the similarity of the two 
proteins. For the expression of CyaY in yeast the p426GPD yeast expression vector was 
used. Since the frataxin is localized to mitochondria in eukaryotes, to target CyaY to the 
mitochondria the leader peptide  of Yfh1p was fused to the N terminal of CyaY. The 
same vector including a wild type YFH1, and an empty vector served as a positive and a 
negative control respectively.  Yeast MPP was expressed and purified by a method 
published earlier. The ferrochelatase protein used in ferrochelatase assay was a kind gift 
of  Dr. Gloria C. Ferreira (University of Florida, Tampa, FL, USA).  
Enzymatic activity assays, determination of the concentration of metabolites 
 The samples used for the assays were prepared by disrupting the cells wit glass 
beads, using Yeast Buster, or collecting different fractions at mitochondria isolation. 
The activity of IPMS was assayed by a fluorimetric method. The activities of malate 
dehydrogenase (MDH), aconitase, and succinate dehydrogenase (SDH) were assayed by 
spectrophotometric methods. Concentration of CoA was measured from the 
deproteinated samples by a flourimetric, citrate levels were determined enzymatically.  
The levels of cytochromes were estimated from isolated mitochondria by 
spectrophotometric method. 
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Results 
The function of Leu5p and hGP 
 Leu5p located in the inner membrane of the mitochondria 
 In order to show Leu5p localized to the inner membrane of the mitochondria we 
studied the import and the exact localization of the  protein. [35S] radioactive labeled 
Leu5p protein were incubated in the presence of isolated, energized mitochondria, then 
the mixture were treated with proteinase K. The Leu5p showed partial resistance against 
the enzyme, what means the protein was taken up by the mitochondria. Furthermore the 
most of the photolytic resistance lost when the outer membrane was broken up by 
hypotonic shock, showing that the Leu5p exposed to the inner membrane space. The 
imported protein was resistant to extraction by treatment with alkaline buffers, 
indicating integration into the membrane. Import of Leu5p into a Tim22p-depleted 
mitochondria was strongly reduced compared to wild-type organelles, and thus appears 
to follow the carrier-specific protein import pathway.  
Phenotypic consequences of the deletion of LEU5 
 To initiate the functional investigation of Leu5p, the entire coding region of 
LEU5 was deleted (Δleu5). In comparison to wild-type cells, mutant cells lacking LEU5 
showed similar growth on rich media containing glucose but displayed strongly retarded 
growth on rich media containing glycerol. However this strain didn’t show auxotrophy 
for leucine. No significant differences in the cytochrome spectra or in oxidative 
phosphorylation of Δleu5 mitochondria were observed compared to wild-type 
organelles. From these data we reasoned that, the Leu5p, as a member of the carrier 
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family, mediates the transport of a substrate required for proper function of an intra 
mitochondrial biosynthetic process. 
Leu5p is required for accumulation of CoA inside mitochondria 
 To identify the substrate of Leu5p, we took advantage of the phenotypical 
observations made for the inactivation of the LEU4 and LEU5 genes. The combined, but 
not the single, mutation of the two genes was reported to result in an auxotrophy for 
leucine. In Δleu4 cells the α-IPM, necessary for the following step in leucine synthesis 
is exclusively produced in the mitochondria by Leu9p localized to the mitochondrial 
matrix. From this piece of data we reasoned that Leu5p, as a mitochondrial carrier, may 
transport a compound necessary for the reaction in which α-IPM formed. In our 
experiments it was identified that among the potential candidates, CoA is the substrate 
what could be transported by Leu5p. This finding has been proven by the strongly 
reduced CoA content of Δleu5 strain compared to wild type.  
The relationship of Leu5p and Cit2p 
 To show an in vivo evidence for the Δleu5 cells reduced mitochondrial CoA 
content, this genotype was combined with the deletion of the peroxisomal citrate 
synthase (Δleu5Δcit2). This strain behaved similarly to Δcit1Δcit2, showed pet 
phenotype, was unable to use glycerol as a carbon source, and showed auxotrophy for 
glutamate, from which we reasoned the citrate synthase located in the mitochondria 
(cit1p) was unable to perform at a satisfying level due to strongly reduced CoA level.  
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The hGP functionally complements the defect of Δleu5  
 The significant homology between hGP and yeast Leu5p suggests a similar 
function of the two proteins. To test this idea, Δleu5 cells were transformed with a 
plasmid carrying the hGP gene. The resulting Δleu5/hGP cells were able for utilizing 
nonfermentable carbon sources and the activity of IMPS, the citrate and the CoA levels 
of mitochondria restored close to that of the wild type. Our data demonstrate that the 
human protein can at least partially replace Leu5p function and suggest a role of hGP in 
the accumulation of CoA in mitochondria. 
Study of CyaY 
Phenotypic consequences of the deletion of cayY 
 The cyaY gene of E. coli was deleted by the homologues recombination of the 
Zeocine antibiotic resistance gene (zeo) to the chromosome. The resulting strain 
(ΔCyaY) was investigated in several conditions where other species, like S. cerevisiae 
are showing dramatic phenotypic changes. However ΔCyaY didn’t show any obvious 
phenotype, including auxotrophy for any nutrient, defect in growth rate, sensitivity 
against oxidative stress or alteration in activity of iron-sulfur cluster enzymes. Together, 
these observations suggest that the function of CyaY may be functionally redundant in 
E. coli, due to the possible presence of one or more suppressors. May be the biological 
function of CyaY only necessary in such a special condition, what not even reproducible 
artificially in laboratory. We therefore reasoned that yeast cells depleted of the 
endogenous Yfh1p would be suitable to interrogate the function of CyaY in iron 
delivery and iron detoxification in a non redundant setting. 
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E. coli CyaY partially complements frataxin depleted yeast  
 Since frataxin in eukaryotes is localized to mitochondria, we engineered a construct 
coding for a chimeric protein (Yfh1–CyaY) consisting of the mitochondrial matrix 
targeting signal of Yfh1p fused in frame with the N-terminus of CyaY. 
This construct was subcloned into a constitutively expressing yeast expression vector 
(p426GDP), and the resulting vector was used to transform the S. cerevisiae GK178 
strain. In this strain, endogenous expression of YFH1 is regulated by a tightly controlled 
mutant GAL1 promoter (gal1*), that provides a close to yfh1Δ state in the presence of 
glucose. Growing the cells in the presence of glucose only  Yfh1-CyaY hybrid protein 
was detectable, but not Yfh1p.  In vivo processing of Yfh1–CyaY generated two 
products. One of them was also detectable after in vitro processing, thus we  reasoned 
that the Yfh1–CyaY hybrid protein imported and processed by mitochondria.  
CyaY complements frataxin depleted yeast 
 Next, we investigated whether Yfh1–CyaY was able to suppress the phenotypic 
changes associated with Yfh1p depletion. After frataxin depletion the strain containing 
CyaY was able to utilize nonfermentable carbon source comparable to the wild type, 
whereas the non complemented strain were growing very poorly.  CyaY was able to 
protect cells similarly to the Yfh1p, when the cells  were exposed to oxidative stress 
generated by MMS or H2O2. When the maintenance of respiratory function was 
analyzed during treatment with iron, we found that CyaY could make the cells a bit less 
tolerant against this effect than the Yfh1p did. The activity of iron-sulfur cluster 
containing enzymes, like aconitase and SDH, in the presence of  Yfh1-CyaY was 
restored to about 80-85% of wild type level.   
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CyaY restores heme synthesis  
 Lastly we investigated whether Yfh1–CyaY was also able to restore heme synthesis 
in frataxin depleted yeast strain.  Whereas the cytochromes were under the detection 
limit in the Yfh1p depleted strain, the presence of Yfh1–CyaY was associated with 
cytochrome content close to that of wild type strain. Based on this observation we 
suspected that CyaY was able to donate iron to ferrochelatase for the biosynthesis of 
heme.  This hypothesis was evidenced in an in vitro reaction using recombinant 
proteins. CyaY was able to provide a definitely higher bioavailable Fe2+ level than the  
buffer itself , but was not as efficient as Yfh1p. In this reaction 75:1 iron to protein ratio 
has been found to be optimal for heme synthesis.  
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